Connor, Clark & Lunn Investment Management Ltd. Idexx Laboratories Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$515.08 - $576.87 $341,498 - $382,464	663 New	663 $357,000
Q3 2022 Nov 10, 2022	SELL	$325.8 - $407.78 $2.28 Million - $2.86 Million	-7,013 Reduced 65.36%	3,716 $1.21 Million
Q2 2022 Aug 05, 2022	BUY	$327.37 - $553.44 $2.39 Million - $4.05 Million	7,311 Added 213.9%	10,729 $3.76 Million
Q1 2022 May 12, 2022	BUY	$466.52 - $631.01 $584,083 - $790,024	1,252 Added 57.8%	3,418 $1.87 Million
Q4 2021 Feb 10, 2022	SELL	$586.54 - $666.48 $960,752 - $1.09 Million	-1,638 Reduced 43.06%	2,166 $1.43 Million
Q3 2021 Nov 12, 2021	SELL	$621.9 - $705.76 $14.3 Million - $16.2 Million	-23,015 Reduced 85.82%	3,804 $2.37 Million
Q2 2021 Aug 12, 2021	SELL	$486.36 - $637.08 $3.3 Million - $4.32 Million	-6,781 Reduced 20.18%	26,819 $16.9 Million
Q1 2021 May 13, 2021	BUY	$465.18 - $551.79 $6.03 Million - $7.15 Million	12,960 Added 62.79%	33,600 $16.4 Million
Q4 2020 Feb 16, 2021	SELL	$383.85 - $499.87 $80,608 - $104,972	-210 Reduced 1.01%	20,640 $10.3 Million
Q3 2020 Nov 12, 2020	BUY	$334.54 - $406.31 $2.68 Million - $3.26 Million	8,025 Added 62.57%	20,850 $8.2 Million
Q2 2020 Aug 13, 2020	BUY	$230.66 - $330.16 $2.59 Million - $3.7 Million	11,220 Added 699.07%	12,825 $4.23 Million
Q1 2020 May 13, 2020	SELL	$182.94 - $290.97 $520,464 - $827,809	-2,845 Reduced 63.93%	1,605 $388,000
Q4 2019 Feb 12, 2020	BUY	$248.66 - $285.01 $385,423 - $441,765	1,550 Added 53.45%	4,450 $1.16 Million
Q3 2019 Nov 13, 2019	BUY	$260.07 - $289.93 $429,115 - $478,384	1,650 Added 132.0%	2,900 $789,000
Q2 2019 Aug 07, 2019	BUY	$215.53 - $275.33 $269,412 - $344,162	1,250 New	1,250 $344,000
Q4 2018 Feb 12, 2019	SELL	$176.18 - $248.92 $361,169 - $510,286	-2,050 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$218.82 - $254.46 $1.82 Million - $2.11 Million	-8,300 Reduced 80.19%	2,050 $512,000
Q2 2018 Aug 02, 2018	SELL	$185.56 - $227.9 $259,784 - $319,060	-1,400 Reduced 11.91%	10,350 $2.26 Million
Q1 2018 May 14, 2018	SELL	$157.81 - $204.73 $15,781 - $20,473	-100 Reduced 0.84%	11,750 $2.25 Million
Q4 2017 Feb 09, 2018	BUY	$147.68 - $168.37 $827,008 - $942,872	5,600 Added 89.6%	11,850 $1.85 Million
Q3 2017 Nov 14, 2017	BUY	$150.32 - $166.46 $578,732 - $640,871	3,850 Added 160.42%	6,250 $972,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,400	2,400 $387,000

Others Institutions Holding IDXX

# of Institutions

1,212

Shares Held

72.5M

Call Options Held

167K

Put Options Held

343K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $34.3B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account